• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Yamasaki Keishi  山崎 啓之

ORCIDConnect your ORCID iD *help
… Alternative Names

YAMASAKI Keishi  山崎 啓之

Less
Researcher Number 30435143
Other IDs
Affiliation (Current) 2022: 崇城大学, 薬学部, 教授
Affiliation (based on the past Project Information) *help 2017 – 2020: 崇城大学, 薬学部, 教授
2009 – 2011: Sojo University, 薬学部, 准教授
Review Section/Research Field
Principal Investigator
Physical pharmacy / Basic Section 47020:Pharmaceutical analytical chemistry and physicochemistry-related
Except Principal Investigator
Basic Section 47060:Clinical pharmacy-related
Keywords
Principal Investigator
アルブミン / ドラッグデリバリー / 膜インターフェイス / 血清アルブミン / 薬物輸送 / α_1-酸性糖タンパク質 / 肺内動態 / 吸入 / タンパク結合 / 薬物デリバリー … More / コンジュゲート / 肺胞 / ナノ粒子 / 細網内皮系回避 / 抗がん剤治療 … More
Except Principal Investigator
膵がん / NOラジカル / ニトロ化合物 Less
  • Research Projects

    (4 results)
  • Research Products

    (61 results)
  • Co-Researchers

    (15 People)
  •  効果的な抗がん剤治療を可能にするアルブミン被覆ステルス化ナノ粒子の開発Principal Investigator

    • Principal Investigator
      山崎 啓之
    • Project Period (FY)
      2020 – 2022
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 47020:Pharmaceutical analytical chemistry and physicochemistry-related
    • Research Institution
      Sojo University
  •  膵がん治療を目的としたアルブミン結合性NOラジカル放出型抗がん剤の開発

    • Principal Investigator
      西 弘二
    • Project Period (FY)
      2020 – 2022
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 47060:Clinical pharmacy-related
    • Research Institution
      Sojo University
  •  Development of novel drug delivery system by controlling of albumin disposition in lungPrincipal Investigator

    • Principal Investigator
      Yamasaki Keishi
    • Project Period (FY)
      2017 – 2019
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Physical pharmacy
    • Research Institution
      Sojo University
  •  Study on the serum protein-mediated drug transport in biological membrane interfacePrincipal Investigator

    • Principal Investigator
      YAMASAKI Keishi
    • Project Period (FY)
      2009 – 2011
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Physical pharmacy
    • Research Institution
      Sojo University

All 2021 2020 2019 2018 2017 2011 2009

All Journal Article Presentation Patent

  • [Journal Article] Processing grapefruit juice with γ-cyclodextrin attenuates its inhibitory effect on cytochrome P450 3A activity.2020

    • Author(s)
      Yamasaki Keishi、Iohara Daisuke、Oyama Yoko、Nishizaki Narumi、Kawazu Seitaro、Nishi Koji、Kadowaki Daisuke、Taguchi Kazuaki、Otagiri Masaki、Seo Hakaru
    • Journal Title

      J Pharm Pharmacol

      Volume: 72 Pages: 356-363

    • DOI

      10.1111/jphp.13212

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18K06774, KAKENHI-PROJECT-17K08261
  • [Journal Article] Cell uptake and anti-tumor effect of liposomes containing encapsulated paclitaxel-bound albumin against breast cancer cells in 2D and 3D cultured models.2020

    • Author(s)
      Okamoto Y, Taguchi K, Imoto S, Chuang VTG, Yamasaki K, Otagiri M
    • Journal Title

      J Drug Deliv Sci Tech

      Volume: 55 Pages: 101381-101381

    • DOI

      10.1016/j.jddst.2019.101381

    • Peer Reviewed / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K08261
  • [Journal Article] Interaction of Aripiprazole with Human α1-Acid Glycoprotein.2019

    • Author(s)
      Nishi K, Sakurama K, Kobashigawa Y, Morioka H, Udo N, Hashimoto M, Imoto S, Yamasaki K, Otagiri M
    • Journal Title

      J Pharm Sci

      Volume: 108 Pages: 3911-3916

    • DOI

      10.1016/j.xphs.2019.09.003

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-17K08261
  • [Journal Article] Further Evidence Regarding the Important Role of Chlorine Atoms of Aripiprazole on Binding to the Site II Area of Human Albumin.2019

    • Author(s)
      Sakurama K, Nishi K, Imoto S, Hashimoto M, Komatsu T, Morita Y, Taguchi K, Otagiri M, Yamasaki K
    • Journal Title

      J Pharm Sci

      Volume: 108 Pages: 1890-1895

    • DOI

      10.1016/j.xphs.2018.11.045

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-17K08261
  • [Journal Article] Preparation, Characterization, and in Vitro/in Vivo Evaluation of Paclitaxel-Bound Albumin-Encapsulated Liposomes for the Treatment of Pancreatic Cancer2019

    • Author(s)
      Okamoto Yuko、Taguchi Kazuaki、Sakuragi Mina、Imoto Shuhei、Yamasaki Keishi、Otagiri Masaki
    • Journal Title

      ACS Omega

      Volume: 4 Pages: 8693-8700

    • DOI

      10.1021/acsomega.9b00537

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-18K06810, KAKENHI-PROJECT-17K08261
  • [Journal Article] α1-Acid Glycoprotein Has the Potential to Serve as a Biomimetic Drug Delivery Carrier for Anti-Cancer Agents.2019

    • Author(s)
      Matsusaka K, Ishima Y, Maeda H, Kinoshita R, Ichimizu S, Taguchi K, Giam Chuang VT, Nishi K, Yamasaki K, Otagiri M, Watanabe H, Maruyama T
    • Journal Title

      J Pharm Sci

      Volume: 108(11) Pages: 3592-3598

    • DOI

      10.1016/j.xphs.2019.07.002

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18H02604, KAKENHI-PROJECT-17K08261
  • [Journal Article] Investigation of anti-tumor effect of doxorubicin-loaded human serum albumin nanoparticles prepared by a desolvation technique.2019

    • Author(s)
      Kimura K, Yamasaki K, Nishi K, Taguchi K, Otagiri M
    • Journal Title

      Cancer Chemother Pharmacol

      Volume: 83 Pages: 1113-1120

    • DOI

      10.1007/s00280-019-03832-3

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18K06810, KAKENHI-PROJECT-17K08261
  • [Journal Article] Enhanced dissolution and oral bioavailability of praziquantel by emulsification with human serum albumin followed by spray drying.2019

    • Author(s)
      Yamasaki K, Taguchi K, Nishi K, Otagiri M, Seo H
    • Journal Title

      Eur J Pharm Sci

      Volume: 139 Pages: 105064-105064

    • DOI

      10.1016/j.ejps.2019.105064

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-17K08261
  • [Journal Article] Pharmacokinetics studies of 4'-cyano-2'-deoxyguanosine, a potent inhibitor of the hepatitis B virus, in rats.2018

    • Author(s)
      Hashimoto M, Taguchi K, Ishiguro T, Kohgo S, Imoto S, Yamasaki K, Mitsuya H, Otagiri M.
    • Journal Title

      J Pharm Pharmacol

      Volume: 70 Pages: 723-731

    • DOI

      10.1111/jphp.12897

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-17K08261
  • [Journal Article] Glutamine Deprivation Enhances Acetyl-CoA Carboxylase Inhibitor-induced Death of Human Pancreatic Cancer Cells.2018

    • Author(s)
      Nishi K, Suzuki M, Yamamoto N, Matsumoto A, Iwase Y, Yamasaki K, Otagiri M, Yumita N
    • Journal Title

      Anticancer Res.

      Volume: 38 Pages: 6683-6689

    • DOI

      10.21873/anticanres.13036

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-17K08261, KAKENHI-PROJECT-17K08429, KAKENHI-PROJECT-18K12086, KAKENHI-PROJECT-16K01381
  • [Journal Article] Crystal structure analysis of human serum albumin complexed with sodium 4-phenylbutyrate2018

    • Author(s)
      Kawai A, Yamasaki K, Enokida T, Miyamoto S, Otagiri M.
    • Journal Title

      Biochem. Biophys. Rep.

      Volume: 13 Pages: 78-82

    • DOI

      10.1016/j.bbrep.2018.01.006

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-17K08261, KAKENHI-PROJECT-15K16128
  • [Journal Article] Pharmacokinetic properties of a novel inosine analog, 4'-cyano-2'-deoxyinosine, after oral administration in rats.2018

    • Author(s)
      Hashimoto M, Taguchi K, Ishiguro T, Kohgo S, Imoto S, Yamasaki K, Mitsuya H, Otagiri M
    • Journal Title

      PLoS One

      Volume: 13

    • DOI

      10.1371/journal.pone.0198636

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-17K08261
  • [Journal Article] Effect of Endogenous Substances on the Binding of Sodium 4- Phenylbutyrate to Human Serum Albumin.2018

    • Author(s)
      Yamasaki K, Nishi K, Enokida T, Taguchi K, Otagiri M
    • Journal Title

      Acta Chim Pharm Indica

      Volume: 8 Pages: 1-6

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-17K08261
  • [Journal Article] Biomimetic carbon monoxide delivery based on hemoglobin vesicles ameliorates acute pancreatitis in mice via the regulation of macrophage and neutrophil activity2018

    • Author(s)
      Taguchi K, Nagao S, Maeda H, Yanagisawa H, Sakai H, Yamasaki K, Wakayama T, Watanabe H, Otagiri M, Maruyama T
    • Journal Title

      Drug Delivery

      Volume: 25 Pages: 1266-1274

    • DOI

      10.1080/10717544.2018.1477860

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-17K08261, KAKENHI-PROJECT-17K08481, KAKENHI-PROJECT-18H02604
  • [Journal Article] Preparation and <i>in Vitro</i> Analysis of Human Serum Albumin Nanoparticles Loaded with Anthracycline Derivatives2018

    • Author(s)
      Kimura K, Yamasaki K, Nakamura H, Haratake M, Taguchi K, Otagiri M.
    • Journal Title

      CHEMICAL & PHARMACEUTICAL BULLETIN

      Volume: 66 Issue: 4 Pages: 382-390

    • DOI

      10.1248/cpb.c17-00838

    • NAID

      130006602056

    • ISSN
      0009-2363, 1347-5223
    • Language
      English
    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-17K08261
  • [Journal Article] Metal-catalyzed oxidation of human serum albumin does not alter the interactive binding to the two principal drug binding sites.2018

    • Author(s)
      Yamasaki K, Nishi K, Anraku M, Taguchi K, Maruyama T, Otagiri M
    • Journal Title

      Biochemistry and Biophysics Reports

      Volume: 14 Pages: 155-160

    • DOI

      10.1016/j.bbrep.2018.05.002

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K08261, KAKENHI-PROJECT-17K08480
  • [Journal Article] Analysis of the Binding of Aripiprazole to Human Serum Albumin: The Importance of a Chloro-Group in the Chemical Structure2018

    • Author(s)
      Sakurama K, Kawai A, Tuan Giam Chuang V, Kanamori Y, Osa M, Taguchi K, Seo H, Maruyama T, Imoto S, Yamasaki K, Otagiri M
    • Journal Title

      ACS Omega

      Volume: 3 Pages: 13790-13797

    • DOI

      10.1021/acsomega.8b02057

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K08261, KAKENHI-PROJECT-15K16128
  • [Journal Article] Albumin-encapsulated liposomes: a novel drug delivery carrier with hydrophobic drugs encapsulated in the inner aqueous core2018

    • Author(s)
      Okamoto Y, Taguchi K, Yamasaki K, Sakuragi M, Kuroda S, Otagiri M.
    • Journal Title

      Journal of Pharmaceutical Sciences

      Volume: 107 Pages: 436-445

    • DOI

      10.1016/j.xphs.2017.08.003

    • Peer Reviewed / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K08261, KAKENHI-PROJECT-16H06314
  • [Journal Article] Crystallographic analysis of the ternary complex of octanoate and N -acetyl- l -methionine with human serum albumin reveals the mode of their stabilizing interactions2017

    • Author(s)
      Kawai A, Chuang VTG, Kouno Y, Yamasaki K, Miyamoto S, Anraku M, Otagiri M.
    • Journal Title

      BBA - Proteins and Proteomics

      Volume: 1865 Pages: 979-984

    • DOI

      10.1016/j.bbapap.2017.04.004

    • Peer Reviewed / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K08261, KAKENHI-PROJECT-17K08480, KAKENHI-PROJECT-15K16128
  • [Journal Article] Interaction of Protizinic Acid with Human Serum Albumin: Site-to-Site Displacement of Protizinic Acid by Ibuprofen.2017

    • Author(s)
      Nishi K, Yamasaki K, Otagiri M
    • Journal Title

      Acta Chim Pharm Indica

      Volume: 7 Pages: 1-9

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-17K08261
  • [Journal Article] The Use of Hemoglobin Vesicles for Delivering Medicinal Gas for the Treatment of Intractable Disorders2017

    • Author(s)
      Taguchi K, Yamasaki K, Sakai H, Maruyama T, Otagiri M
    • Journal Title

      Journal of Pharmaceutical Sciences

      Volume: 106 Pages: 2392-2400

    • DOI

      10.1016/j.xphs.2017.04.006

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-17K08261, KAKENHI-PROJECT-17K08481, KAKENHI-PROJECT-17H02087
  • [Journal Article] Long chain fatty acids alter the interactive binding of ligands to the two principal drug binding sites of human serum albumin.2017

    • Author(s)
      Yamasaki K, Hyodo S, Taguchi K, Nishi K, Yamaotsu N, Hirono S, Chuang VTG, Seo H, Maruyama T, Otagiri M.
    • Journal Title

      PLoS One

      Volume: 12 Pages: 1-15

    • DOI

      10.1371/journal.pone.0180404

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K08261
  • [Journal Article] Recombinant Human Serum Albumin Containing 3 Copies of Domain I, Has Significant <i>in Vitro</i> Antioxidative Capacity Compared to the Wild-Type2017

    • Author(s)
      Matsushita S, Nishi K, Iwao Y, Ishima Y, Watanabe H, Taguchi K, Yamasaki K, Maruyama T, Otagiri M.
    • Journal Title

      Biol. Pharm. Bull.

      Volume: 40 Issue: 10 Pages: 1813-1817

    • DOI

      10.1248/bpb.b17-00528

    • NAID

      130006110574

    • ISSN
      0918-6158, 1347-5215
    • Language
      English
    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-17K08261
  • [Journal Article] Species Differences in the Binding of Sodium 4-Phenylbutyrate to Serum Albumin2017

    • Author(s)
      Yamasaki K, Enokida T, Taguchi K, Miyamura S, Kawai A, Miyamoto S, Maruyama T, Seo H, Otagiri M.
    • Journal Title

      J. Pharm. Sci.

      Volume: 106 Pages: 2860-2867

    • DOI

      10.1016/j.xphs.2017.04.025

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-17K08261, KAKENHI-PROJECT-15K16128
  • [Journal Article] Histidine146 of human serum albumin plays a prominent role at the interface of subdomains IA and IIA in allosteric ligand binding2011

    • Author(s)
      Kaneko K, Chuang VT, Minomo A, Yamasaki K, Bhagavan NV, Maruyama T, Otagiri M
    • Journal Title

      IUBMB Life

      Volume: 63 Pages: 277-285

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21590054
  • [Journal Article] Competitive Displacement of Serum Protein Binding of Radiopharmaceuticals with Amino Acid Infusion Investigated with N-Isopropyl-p-123I-Iodoamphetamine2009

    • Author(s)
      Kuga N, Shikano N, Takamura N, Nishii R, Yamasaki K, Kobayashi M, Nagamachi S, Tamura S, Kawai K
    • Journal Title

      J. Nucl. Med

      Volume: 50 Pages: 1378-1383

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21590054
  • [Patent] sj2001UU2020

    • Inventor(s)
      西弘二、山崎啓之、井本修平、小田切優樹、別府拓豪
    • Industrial Property Rights Holder
      西弘二、山崎啓之、井本修平、小田切優樹、別府拓豪
    • Industrial Property Rights Type
      特許
    • Industrial Property Number
      2020-010513
    • Filing Date
      2020
    • Data Source
      KAKENHI-PROJECT-20K07193
  • [Presentation] ヒト膵がん細胞に対するニトロ化フェニル酪酸の細胞死誘導効果2021

    • Author(s)
      別府 拓豪、西 弘二、井本 修平、異島 優、月川 健士、小田切 優樹、山崎 啓之
    • Organizer
      日本薬学会第141年会
    • Data Source
      KAKENHI-PROJECT-20K07193
  • [Presentation] アルブミンとの混合噴霧乾燥によるプラジカンテル粒子の調製と溶出性・経口吸収性評価2020

    • Author(s)
      山崎 啓之、田口 和明、西 弘二、小田切 優樹、瀬尾 量
    • Organizer
      日本薬学会第140年会
    • Data Source
      KAKENHI-PROJECT-17K08261
  • [Presentation] ヒト膵がん細胞に対するニトロ化フェニル酪酸の細胞死誘導効果2020

    • Author(s)
      別府 拓豪、西 弘二、井本 修平、小田切 優樹、山崎 啓之
    • Organizer
      日本薬学会第140年会
    • Data Source
      KAKENHI-PROJECT-20K07193
  • [Presentation] ヒト膵がん細胞に対するニトロ化フェニル酪酸の細胞死誘導効果2020

    • Author(s)
      別府 拓豪、西 弘二、井本 修平、小田切 優樹、山崎 啓之
    • Organizer
      日本薬剤学会第35年会
    • Data Source
      KAKENHI-PROJECT-20K07193
  • [Presentation] 脱溶媒法によるラクトフェリンナノ粒子に与える調製パラメーターの影響2020

    • Author(s)
      田口 和明、橋本 麻衣、中山 真雪、榎木 裕紀、西 弘二、松元 一明、瀬尾 量、小田切 優樹、山崎 啓之
    • Organizer
      日本薬学会第140年会
    • Data Source
      KAKENHI-PROJECT-17K08261
  • [Presentation] ヒト膵がん細胞に対するニトロ化フェニル酪酸の細胞死誘導効果2020

    • Author(s)
      別府 拓豪、西 弘二、井本 修平、小田切 優樹、山崎 啓之
    • Organizer
      日本薬学会第140年会
    • Data Source
      KAKENHI-PROJECT-17K08261
  • [Presentation] 血清アルブミンを活用した環境応答性高分子化抗がん剤の作製と評価2019

    • Author(s)
      月川 健士、井本 修平、山崎 啓之、堤 敏彦、横山 祥子 、小田切 優樹
    • Organizer
      日本薬学会第139年会
    • Data Source
      KAKENHI-PROJECT-17K08261
  • [Presentation] 健常ラット及び出血性ショックラットに対するヘモグロビン小胞体輸血が肝チトクロームP450の発現量に与える影響2019

    • Author(s)
      小田切 優樹、得能 正裕、山崎 啓之、大槻 純男、酒井 宏水、田口 和明
    • Organizer
      日本薬学会第139年会
    • Data Source
      KAKENHI-PROJECT-17K08261
  • [Presentation] 脱溶媒和法により調製したドキソルビシン封入ヒト血清アルブミンナノ粒子の抗腫瘍効果に関する検討2019

    • Author(s)
      山崎 啓之, 木村 虎太郎, 西 弘二, 猪原 彩希, 大島 千佳, 井本 修平, 田口 和明, 小田切 優樹
    • Organizer
      第35回日本DDS学会学術集会
    • Data Source
      KAKENHI-PROJECT-17K08261
  • [Presentation] ヒトα1-酸性糖タンパク質に対するアリピプラゾールの結合特性評価2019

    • Author(s)
      西 弘二、櫻間 啓基 、井本 修平、山崎 啓之、小田切 優樹
    • Organizer
      日本薬学会第139年会
    • Data Source
      KAKENHI-PROJECT-17K08261
  • [Presentation] B型肝炎ウイルス新規候補治療薬 4'-CN-2'-deoxyguanosine の急性肝傷害モデルラットにおける体内動態解析2019

    • Author(s)
      橋本 麻衣、田口 和明、井本 修平、山崎 啓之、満屋 裕明、小田切 優樹
    • Organizer
      日本薬学会第139年会
    • Data Source
      KAKENHI-PROJECT-17K08261
  • [Presentation] ドキソルビシン封入ヒト血清アルブミンナノ粒子のin vitroおよびin vivo機能評価2019

    • Author(s)
      山崎 啓之、木村 虎太郎、西 弘二、田口 和明、小田切 優樹
    • Organizer
      日本薬学会第139年会
    • Data Source
      KAKENHI-PROJECT-17K08261
  • [Presentation] グレープフルーツのCYP3A活性阻害におよぼすシクロデキストリン処理の影響2019

    • Author(s)
      山崎 啓之, 小山 陽子, 西崎 成美, 河津 誠太郎, 庵原 大輔, 田口 和明, 門脇 大介, 小田切 優樹, 瀬尾 量
    • Organizer
      第29回日本医療薬学会年会
    • Data Source
      KAKENHI-PROJECT-17K08261
  • [Presentation] 各種病態時におけるダプトマイシンのタンパク結合変化のin vitroでの予測2018

    • Author(s)
      山崎 啓之、櫻間 啓基、田口 和明、瀬尾 量、小田切 優樹
    • Organizer
      日本薬剤学会 第33年会
    • Data Source
      KAKENHI-PROJECT-17K08261
  • [Presentation] ヒト血清アルブミン分子上サイトⅡへのアリピプラゾール結合における塩素原子の重要性2018

    • Author(s)
      櫻間 啓基、井本 修平、河合 聡人、田口 和明、瀬尾 、小田切 優樹、山崎 啓之
    • Organizer
      第35回日本薬学会九州支部大会
    • Data Source
      KAKENHI-PROJECT-17K08261
  • [Presentation] 一酸化炭素結合型ヘモグロビン小胞体の抗炎症作用機序の解明と急性膵炎治療への応用2018

    • Author(s)
      田口 和明、永尾 紗理、前田 仁志、酒井 宏水、山崎 啓之、丸山 徹、小田切 優樹
    • Organizer
      日本薬剤学会 第33年会
    • Data Source
      KAKENHI-PROJECT-17K08261
  • [Presentation] ヘモグロビン小胞体大量投与が薬物の体内動態に与える影響2018

    • Author(s)
      西川 紗綾、得能 正裕、田口 和明、山崎 啓之、酒井 宏水、小田切 優樹
    • Organizer
      第35回日本薬学会九州支部大会
    • Data Source
      KAKENHI-PROJECT-17K08261
  • [Presentation] 脱溶媒和法により調製したドキソルビシン封入ヒト血清アルブミンナノ粒子の機能評価2018

    • Author(s)
      山崎 啓之、木村 虎太郎、田口 和明、中村 秀明、原武 衛、小田切 優樹
    • Organizer
      第34回日本DDS学会学術集会
    • Data Source
      KAKENHI-PROJECT-17K08261
  • [Presentation] 抗がん剤用DDSキャリアとしてのアルブミンナノ粒子の有用性評価2018

    • Author(s)
      山崎 啓之, 木村 虎太郎, 中村 秀明, 原武 衛, 田口 和明, 小田切 優樹
    • Organizer
      日本薬学会第138年会
    • Data Source
      KAKENHI-PROJECT-17K08261
  • [Presentation] パクリタキセル-アルブミン内包リポソームの膵臓がん治療への応用2018

    • Author(s)
      田口 和明、岡本 侑子、櫻木 美菜、山崎 啓之、小田切 優樹
    • Organizer
      第34回日本DDS学会学術集会
    • Data Source
      KAKENHI-PROJECT-17K08261
  • [Presentation] フェニル酪酸ナトリウムの動物種アルブミンへの結合特性評価2017

    • Author(s)
      榎田泰介、山崎啓之、田口和明、宮本秀一、小田切優樹
    • Organizer
      日本薬剤学会 第32年会
    • Data Source
      KAKENHI-PROJECT-17K08261
  • [Presentation] ダプトマイシンのタンパク結合特性と生体内変動因子の影響2017

    • Author(s)
      櫻間啓基、田口和明、瀬尾量、小田切優樹、山崎啓之
    • Organizer
      第34回日本薬学会九州支部大会
    • Data Source
      KAKENHI-PROJECT-17K08261
  • [Presentation] 抗がん剤封入アルブミンナノ粒子の調製とin vitro評価2017

    • Author(s)
      山崎桃子、木村虎太郎、山崎啓之、田口和明、中村秀明、原武衛、小田切優樹
    • Organizer
      第34回日本薬学会九州支部大会
    • Data Source
      KAKENHI-PROJECT-17K08261
  • [Presentation] Comparative study of sodium 4-phenylbutyrate binding to albumins from different species.2017

    • Author(s)
      Keishi Yamasaki, Taisuke Enokida, Akito Kawai, Shuichi Miyamoto, Kazuaki Taguchi, Toru Maruyama, Hakaru Seo, Masaki Otagiri
    • Organizer
      AFPS2017
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K08261
  • [Presentation] 急性膵炎に対する一酸化炭素結合型ヘモグロビン小胞体の有用性評価2017

    • Author(s)
      田口和明、永尾紗理、酒井宏水、山崎啓之、丸山徹、小田切優樹
    • Organizer
      日本薬剤学会 第32年会
    • Data Source
      KAKENHI-PROJECT-17K08261
  • [Presentation] パクリタキセル-アルブミン内包リポソームの作製と有用性評価2017

    • Author(s)
      岡本侑子、田口和明、櫻木美菜、山崎啓之、小田切優樹
    • Organizer
      第33回日本DDS学会学術集会
    • Data Source
      KAKENHI-PROJECT-17K08261
  • [Presentation] X線結晶構造解析に基づくオクタン酸ナトリウムおよびN-アセチル-L-メチオニンのヒト血清アルブミン安定化機構の解明2017

    • Author(s)
      山崎啓之, 河合聡人, 河野陽介, 宮本秀一, 田口和明, 安楽 誠, 小田切優樹
    • Organizer
      日本薬剤学会 第32年会
    • Data Source
      KAKENHI-PROJECT-17K08261
  • [Presentation] 4-フェニル酪酸ナトリウムの血清アルブミン結合における種差2017

    • Author(s)
      山崎啓之、榎田泰介、田口和明、宮村重幸、河合聡人、宮本秀一、丸山徹、瀬尾量、小田切優樹
    • Organizer
      薬物動態学会 第32年会
    • Data Source
      KAKENHI-PROJECT-17K08261
  • [Presentation] ヘモグロビン小胞体の難治性炎症疾患治療薬としての応用使用2017

    • Author(s)
      田口和明,永尾紗理,酒井宏水,山崎啓之,丸山 徹,小田切優樹
    • Organizer
      第24回日本血液代替物学会年次大会
    • Data Source
      KAKENHI-PROJECT-17K08261
  • [Presentation] 抗がん剤封入ヒト血清アルブミンナノ粒子の物性評価とin vitro評価2017

    • Author(s)
      木村虎太郎、山崎啓之、田口和明、中村秀明、原武衛、小田切優樹
    • Organizer
      第33回日本DDS学会学術集会
    • Data Source
      KAKENHI-PROJECT-17K08261
  • [Presentation] Antioxidative property of recombinant human serum albumin containing 3 copies of domain I in vitro.2017

    • Author(s)
      Koji Nishi, Sadaharu Matsushita, Yasunori Iwao, Yu Ishima, Hiroshi Watanabe, Kazuaki Taguchi, Keishi Yamasaki, Toru Maruyama, Masaki Otagiri
    • Organizer
      AFPS2017
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K08261
  • [Presentation] アリピプラゾールのヒト血清アルブミン結合に関する検討2017

    • Author(s)
      金森陽子、櫻間啓基、長美友、田口和明、瀬尾量、小田切優樹、山崎啓之
    • Organizer
      第34回日本薬学会九州支部大会
    • Data Source
      KAKENHI-PROJECT-17K08261
  • [Presentation] In vitro evaluation for antioxidant activities of dietary supplements2009

    • Author(s)
      Yamasaki K
    • Organizer
      Asian Federation for Pharmaceutical Sciences
    • Place of Presentation
      九州大学
    • Year and Date
      2009-10-17
    • Data Source
      KAKENHI-PROJECT-21590054
  • [Presentation] In vitro evaluation for antioxidant activities of dietary supplements.2009

    • Author(s)
      Yamasaki K
    • Organizer
      Asian Federation for Pharmaceutical Sciences
    • Place of Presentation
      九州大学
    • Year and Date
      2009-10-17
    • Data Source
      KAKENHI-PROJECT-21590054
  • 1.  OTAGIRI Masaki (80120145)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 3 results
  • 2.  西 弘二 (00398249)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 4 results
  • 3.  異島 優 (00457590)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 1 results
  • 4.  井本 修平 (20447189)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 3 results
  • 5.  SEO Hakaru
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 6.  KADOWAKI Daisuke
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 7.  IWASE Yumiko
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 8.  SAKAI Hiromi
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 9.  WATANABE Hiroshi
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 2 results
  • 10.  MARUYAMA Toru
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 2 results
  • 11.  安楽 誠
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 2 results
  • 12.  河合 聡人
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 4 results
  • 13.  弓田 長彦
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 14.  田口 和明
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 4 results
  • 15.  黒田 俊一
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results

URL: 

Are you sure that you want to connect your ORCID iD to this researcher?
* This action can be performed only by the researcher themselves.

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi